Recent study doesn’t change Topamax, Depakote birth defects risks The maker of a topiramate-containing antiepileptic drug co-sponsored a study which showed that its own drug produced less severe side effects than another medication, valproate, in treating juvenile myoclonic epilepsy patients. The bad news in this therapeutic duel is that each drug is linked to an increased risk of birth defects in the babies of women who take either drug while they are ...
June 17, 2013 - Injury Board